Taysha Gene Therapies Inc. (TSHA) Social Stream
TAYSHA GENE THERAPIES INC (TSHA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering TAYSHA GENE THERAPIES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 11 | $60 | $34 | $45.6 | $1.67 | 2630.54% |
| 2021-11-11 | 11 | $60 | $33 | $44.9 | $1.67 | 2588.62% |
| 2022-01-27 | 12 | $60 | $28 | $43.363 | $1.67 | 2496.59% |
| 2022-01-31 | 12 | $60 | $28 | $42.545 | $1.67 | 2447.6% |
| 2022-03-01 | 13 | $60 | $25 | $41.083 | $1.67 | 2360.06% |
| 2022-03-09 | 14 | $60 | $25 | $39.923 | $1.67 | 2290.6% |
| 2022-04-04 | 14 | $45 | $22 | $32.923 | $1.67 | 1871.44% |
| 2022-05-17 | 14 | $45 | $22 | $32.076 | $1.67 | 1820.72% |
| 2022-05-19 | 14 | $45 | $9 | $30.846 | $1.67 | 1747.07% |
| 2022-05-24 | 14 | $45 | $9 | $29.785 | $1.67 | 1683.53% |
| 2022-08-12 | 11 | $38 | $9 | $26.272 | $1.67 | 1473.17% |
| 2022-08-15 | 11 | $38 | $16 | $27.8 | $1.67 | 1564.67% |
| 2022-10-26 | 10 | $38 | $15 | $24.4 | $1.67 | 1361.08% |
| 2022-11-08 | 11 | $38 | $15 | $23.636 | $1.67 | 1315.33% |
| 2022-11-09 | 11 | $38 | $15 | $22.909 | $1.67 | 1271.8% |
| 2022-11-14 | 11 | $23 | $3 | $16.083 | $1.67 | 863.05% |
| 2022-12-21 | 12 | $24 | $3 | $16.692 | $1.67 | 899.52% |
| 2023-01-04 | 12 | $24 | $3 | $16.384 | $1.67 | 881.08% |
| 2023-01-30 | 12 | $24 | $3 | $14.846 | $1.67 | 788.98% |
| 2023-02-01 | 13 | $19 | $1.5 | $7.961 | $1.67 | 376.71% |
| 2023-03-29 | 12 | $19 | $1.5 | $7.961 | $1.67 | 376.71% |
| 2023-03-30 | 12 | $19 | $0.7 | $6.746 | $1.67 | 303.95% |
| 2023-05-12 | 11 | $19 | $0.7 | $7.141 | $1.67 | 327.6% |
| 2023-08-15 | 11 | $19 | $2 | $8 | $1.67 | 379.04% |
| 2023-08-16 | 11 | $19 | $2 | $7.666 | $1.67 | 359.04% |
| 2023-09-20 | 11 | $19 | $2 | $7.333 | $1.67 | 339.1% |
| 2023-09-21 | 11 | $19 | $2 | $7.25 | $1.67 | 334.13% |
| 2023-10-24 | 10 | $19 | $2 | $7.409 | $1.67 | 343.65% |
| 2023-11-15 | 10 | $7.5 | $2 | $5.388 | $1.67 | 222.63% |
| 2023-11-16 | 10 | $19 | $2 | $6.85 | $1.67 | 310.18% |
The Trend in the Analyst Price Target
Over the past 21 months, TSHA's average price target has gone down $35.58.
TSHA reports an average of 519.88% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-01 | 13 | 24.0 | 3.0 | 14.538 | 1.21 | 1101.49% |
| 2023-02-01 | 12 | 19.0 | 1.5 | 7.961 | 1.21 | 557.93% |
| 2023-08-15 | 11 | 19.0 | 2.0 | 8.000 | 2.18 | 266.97% |
| 2023-09-21 | 10 | 19.0 | 2.0 | 7.250 | 3.03 | 139.27% |
| 2023-11-16 | 11 | 7.5 | 2.0 | 5.500 | 1.57 | 250.32% |
TSHA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.3 | 8 | 1 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 35 weeks, TSHA's average broker recommendation rating improved by 0.3.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, TAYSHA GENE THERAPIES INC's upside potential (average analyst target price relative to current price) is greater than 4281.03% of them.
- TSHA has a lower variance in analysts' estimates than -3995.37% of all US stocks.
- TSHA has a greater number of analysts covering the stock than 4430.26% of stocks in the small market cap category.
- In the context of stocks in the small market cap category, TAYSHA GENE THERAPIES INC's average analyst price target is higher than 2119.15% of them.
In the Pharmaceutical Products industry, OPT, TARS, and ALGS are the three stocks most similar to TAYSHA GENE THERAPIES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding TSHA using the data that counts. Try POWR Ratings for free.